Proxima Research Uzbekistan Business Dinner: 2025 Results and a Focus on 2026

On February 5, 2026, a business dinner organized by Proxima Research Uzbekistan took place in Tashkent. The event was dedicated to summarizing the results of 2025 and discussing the key priorities for the pharmaceutical industry’s development in 2026.

The event brought together more than 60 representatives of the Republic of Uzbekistan’s pharmaceutical market, serving as a professional platform for sharing experiences, analyzing market trends, and discussing relevant industry topics.

Key Topics of the Event: The Republic of Uzbekistan’s Pharmaceutical Market

As part of the business program, participants discussed several topical issues, including:

• An overview of global pharmaceutical market trends;

• An analytical review of the pharmaceutical market of Uzbekistan based on the results of 2025;

• A panel discussion, “Industry Transformation: How the Pharma Business Is Adapting to the New Reality.”

Business Dinner Program

The event opened with a welcome speech by Oleg Dobranchuk, Chief Commercial Officer of Proxima Research, who expressed his gratitude to guests and partners for their trust and contribution to the development of the pharmaceutical industry. In his presentation, speaker also shared an overview of key global pharmaceutical trends and outlined the main directions for market development in 2026. The speaker emphasized the innovative Proxima Cloud CRM system with an AI chatbot, designed to increase sales efficiency and automate routine processes. Special attention was given to the GeoForce tool, which enables the assessment and optimization of territorial potential, balances medical representatives’ areas of responsibility, and creates the most effective coverage models.

This was followed by a presentation from Vitaliy Kim, Director of Proxima Research Uzbekistan, who delivered a detailed analytical review of the pharmaceutical market based on 2025 results. The analysis was based on data from the company’s products Market Audit, Promo Test, and Rx Test, providing participants with an objective and practice-oriented view of the market.

The business program concluded with a panel discussion featuring representatives of pharmaceutical companies. During the conversation, participants addressed the challenges of industry transformation, new business models, and how companies are adapting to changing market conditions.

Pharmaceutical Networking

The final part of the business program was a panel discussion moderated by Tatiana Kasimova, Marketing Director at Incare, featuring representatives from pharmaceutical companies. During the discussion, participants addressed the challenges of industry transformation, new business models, and how companies are adapting to changing market conditions.

Proxima Research Uzbekistan extends its sincere gratitude to all guests for their active participation, insightful questions to the speakers, and positive feedback. We highly value your trust and look forward to meeting you again.

Get speakers’ presentations